NCT00347061View on ClinicalTrials.gov

Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

afuzosin

Trial Locations (1)

Unknown

Sanofi-Aventis, Tokyo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00347061 - Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH | Biotech Hunter | Biotech Hunter